Egis World
Egis' products are sold to 100 countries.
Over the next few years, Egis Pharmaceuticals PLC will invest EUR 21.1 million to increase its capacity at its Körmend site. To finance these developments, Egis will use its own capital and a government subsidy of EUR 3.4 million – announced Csaba Poroszlai, CEO of Egis. In total, the company will devote more than EUR 50 million to the development of the Körmend site of Egis since 2019. More

Night of Museums - first time at Egis

The Egis Science and Technology Centre welcomes visitors on the longest night of the year

More

A unique chemistry competition sponsored by Egis

Although the Researchers' Night will not take place until autumn, one of the side events of the large-scale event is already open for registration: the thought-provoking chemistry competition is sponsored by Egis.

More

Csaba Poroszlai elected vice president of MAGYOSZ

Mr. Csaba Poroszlai, CEO of Egis and dr Tamás Rónay CEO of Sanofi-Aventis and Chinoin were elected vice presidents of the Hungarian Pharmaceutical Manufacturers’ Association (MAGYOSZ) at the Association’s annual general meeting. The executive director of Meditop Kft., dr Dávid Greskovits, will hold the position of president for another three years. Mr. Csaba Poroszlai has also become the member of the presidential board.

More

Egis hosted jobseekers in five job fairs

There were five opportunities to meet us this spring.

More
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox